Co-Diagnostics, Inc. Common Stock (CODX) is a publicly traded Healthcare sector company. As of May 21, 2026, CODX trades at $3.02 with a market cap of $4.94M and a P/E ratio of -0.06. CODX moved +21.32% today. Year to date, CODX is -58.36%; over the trailing twelve months it is -71.03%. Its 52-week range spans $1.26 to $46.50. Rallies surfaces CODX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CODX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CODX recently traded at $3.02. Market cap is $4.94M. P/E ratio is -0.06. Revenue is $718.17K.
| Metric | Value |
|---|---|
| Price | $3.02 |
| Market Cap | $4.94M |
| P/E Ratio | -0.06 |
| EPS | $-39.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.50 |
| 52-Week Low | $1.26 |
| Volume | 13.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $718.17K |
| Net Income | $-48.50M |
| Gross Margin | 45.06% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $622.49K | $-46.90M | $-35.25 |
| 2024 | $3.92M | $-37.64M | $-1.24 |
| 2023 | $6.81M | $-35.33M | $-1.20 |
| 2022 | $34.22M | $-14.24M | $-0.45 |
CODX analyst coverage data. Average price target: $0.00.